Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03951662

Immunology of HIV and Alcoholic Hepatitis

Effects of Alcoholic Hepatitis on Immunological and Virological Profiles in HIV-Positive Patients

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Indiana University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is prospective, longitudinal cohort study involving HIV-positive, antiretroviral (ART)-treated, heavy alcohol drinking participants who have and do not have alcoholic hepatitis.

Detailed description

The primary objective of this study is to determine the relationships between alcohol consumption and HIV-related pathogenic processes (microbial translocation, immune activation, inflammation, HIV replication, and hepatitis). Two study groups will be assembled and followed longitudinally over one year to address this objective. Group 1 will include HIV-positive, ART-treated, heavy alcohol drinkers who have alcoholic hepatitis. Group 2 will include HIV-positive, ART-treated, heavy alcohol drinkers who do not have alcoholic hepatitis. Both groups will undergo similar study procedures and follow-up.

Conditions

Interventions

TypeNameDescription
OTHERAlcoholic Hepatitis GroupAlcoholic hepatitis is defined as having a total bilirubin level \>3mg/dL and AST level\>50U/L
OTHERHeavy Drinking Controls without HepatitisNormal levels of AST, ALT and total bilirubin and without evidence of cirrhosis or hepatosplenomegaly

Timeline

Start date
2020-07-01
Primary completion
2020-09-30
Completion
2020-09-30
First posted
2019-05-15
Last updated
2021-01-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03951662. Inclusion in this directory is not an endorsement.